Research and Innovation at the Heart of an Exceptional Partnership
Laprophan, a pioneer in the pharmaceutical industry in Morocco, has a long tradition of research and development and several previous synergies with Moroccan and European universities in various fields (formulation, physical chemistry, pharmacotoxicology, microbiology, clinical research, molecular chemistry). The very first research agreement signed by Laprophan with the academic world dates back to 1978 (with the Faculty of Medicine and Pharmacy of Casablanca). This tradition has led to the emergence of several patents for inventions and innovations that are now marketed in Morocco and abroad.
For this Research alliance, Laprophan and USMBA, the top Moroccan university according to the "Times Higher Education" ranking and the only Moroccan university to appear in the Top 800 of global universities according to the same ranking, have come together to exchange their expertise and know-how in this area.
Laprophan and the Sidi Mohamed Ben Abdellah University of Fès (USMBA) are joining forces to promote biomedical research in Morocco.
This alliance was formalized through the signing, on Thursday, April 8, 2021, of an important agreement covering several themes: the medical and paramedical valorization of medicinal and aromatic plants, clinical toxicology studies, and preclinical and clinical studies in several therapeutic areas, particularly those related to the medical valorization of therapeutic cannabis.
For Dr. Farid BENNIS, Chairman and CEO of Laprophan and holder of several invention patents, "The signing of this agreement is, first and foremost, a recognition of USMBA's commitment to the development of scientific research and innovation, but also and above all, a contribution to the growth of a true Moroccan biomedical research capable of valorizing the therapeutic potential of aromatic and medicinal plants, particularly the therapeutic uses of cannabis derivatives."
Professor Radouane Mrabet, President of USMBA, expressed "his great satisfaction at seeing this partnership established with a national company recognized for its commitment to biomedical research in Morocco." He also noted that "Sidi Mohamed Ben Abdellah University of Fès has a long tradition in medical and pharmacological research, particularly in the valorization of medicinal and aromatic plants, including medical cannabis, as well as in clinical trials for the treatment of refractory epilepsies based on medical cannabis."
About Sidi Mohamed Ben Abdellah University:
USMBA is a university renowned for the quality of its training and the research and valorization work carried out through its 13 university establishments, composed of 58 research laboratories and 1700 teacher-researchers who have registered 24 national patents and 4 international ones. Additionally, USMBA has ensured its prominence by establishing 104 national agreements and 140 at the international level.
About Laprophan Laboratories:
A pioneer in the Moroccan pharmaceutical industry, Laprophan is a national pharmaceutical company that has been operating in the drug sector since 1949.
Laprophan stands out for its long tradition of research and holds 5 national and international patents for innovative drugs resulting from its own research. Laprophan is a key player in health in Morocco with a broad portfolio of over 400 drugs covering several therapeutic areas.